BMJ Open publishes all reviews undertaken for accepted manuscripts. Reviewers are asked to complete a checklist review form (http://bmjopen.bmj.com/site/about/resources/checklist.pdf) and are provided with free text boxes to elaborate on their assessment. These free text comments are reproduced below.
Introduction
• Line 14-18 reference: I am unable to find an English translation for this reference. Is the CRBSI and HAI rates for Spain or international rates?
• Line 18 reference for CRBSI is actually for CLABSI. Please adjust accordingly.
• Line 20 The device related BSI caused by PVCs has been incorrectly written, should be 1%, 0.5 per 1000 catheter days.
• Line 23 please find new references, Plowman 1999 is old and Lobo 2005 does not support your statement
• References 10 and 11 are old is it possible to find a more recent reference? Methods • Page 6. Is the Infusion Nursing the Infusion Nurses Society? If so write in full.
• Table 1 : not all the descriptors are MeSH terms. Could you please remove MeSH from this table description or identify which are MeSH and which are keyword terms. Eligibility criteria • Please write IOM in full as this has not been previously defined.
Data management and extraction • Line 28: Could you please explain the process and reason for randomizing documents for the reviewers to obtain a broader perspective. This does not appear to be in keeping with your review. Data analysis • Table 2 : This table is unnecessary and should be removed.
• Consider removing Table 3 and include as text in the methods section. Results • It would be useful for the reader to know which CPGs were excluded. Please add the references to your exclusions? Why were the INS guidelines excluded? Please write JBI in full. Your text identifies 14 excluded papers, the PRISMA flow diagram mentions 15 excluded papers but the reasons for exclusion on the flow diagram equal 16. Please correct.
• Pg 12: It would be useful for the reader to know which guidelines scored lowest for particular items within the Domains. Could this please be added? For example: Additionally, item 5 (the views and preferences of the target population have been sought') in the AGREE II instrument the lowest score, being included in only four CPGs (add references for the four CPGs) • Line 9: Please remove the before item • Could you please rewrite the last sentence on page 12 as it was difficult to understand? Regarding the information… Overall assessment • Please list the average scores at the beginning of this section. Consider rewording to the average score of CPGS was 62%(range 38% -90%). In its current format the reader may think you are referring to the average score for the NICE and Ministry of Health in Spain CPGs.
• Table 5 . Please change title GPC to CPG • Table 5 . Please use additional identifiers for the included CPGs e.g. author (year) Agreement among reviewers • In your paper you have mentioned a substantial agreement of (K = 0.2) but table 3 refers to this as a moderate agreement. Please correct. Discussion • Please consider restructured your first sentence, paragraph 2. e.g. However, we identified low scores on other equally crucial domains for effective implementation including 'stakeholder involvement', methodological rigor and applicability'.
• Line 50 please change as important to is as important • Your discussion addresses the adoption of guidelines into clinical practice and the processes to support this. However, this was not the question you were asking or supported by your results. Please restructure your discussion to address the results of your review. Conclusion • Your conclusion needs to summarize the findings of your review.
REVIEWER
Nicole C Gavin Royal Brisbane and Women's Hospital; Australia REVIEW RETURNED 23-Apr-2018
GENERAL COMMENTS
Title:
The title of the paper does not fit with the content of the manuscript. I was expecting the evidence in the CPG to be appraised but actuallythe quality of the guidelines themselves are being appraised.
Purpose:
The purpose of the study is different in the abstract and the introduction. Data management and extraction Line 28: Could you please explain the process and reason for randomizing documents for the reviewers to obtain a broader perspective. This does not appear to be in keeping with your review. R: Many thanks for this clarification. We followed the suggestions of Birken (2015), the outputs of the AGREE tool can be limited due to the familiarity of the results, so we were decided to randomize the order of review to avoid this bias (Birken SA, et al. Guidelines for the use of survivorship care plans: a systematic quality appraisal using the AGREE II instrument. Implement Sci 2015;10:63). appendix 2) . The correct number of excluded papers has been changed. And, we have now written JBI in full. Initially, we considered to include INS guidelines within the review, but this guide was constructed to be a standard of practice operated by professionals, and not for patients. In addition, INS guidelines does not support the evaluation of AGREE tool. We appreciate your review, it has clarified a subject that may be difficult to understand.
Data analysis
Pg 12: It would be useful for the reader to know which guidelines scored lowest for particular items within the Domains. Could this please be added? For example: Additionally, item 5 (the views and preferences of the target population have been sought') in the AGREE II instrument the lowest score, being included in only four CPGs (add references for the four CPGs) R: We are grateful to the reviewer for this suggestion, which we have followed. We believe that the readers will have improved understanding of the strengths and weaknesses of each guideline.
Line 9: Please remove the before item R: Thank you, we have amended.
Could you please rewrite the last sentence on page 12 as it was difficult to understand? Regarding the information… R: This has been changed. We have now amended to "The CPGs were rated negatively as they did not take into account possible enabling factors for implementation, strategies to improve adoption, resource considerations or availability of monitoring indicators."
Overall assessment Please list the average scores at the beginning of this section. Consider rewording to the average score of CPGS was 62%(range 38% -90%). In its current format the reader may think you are referring to the average score for the NICE and Ministry of Health in Spain CPGs. R: This has been changed according the reviewer comments. Table 5 . Please change title GPC to CPG R: Many thanks for highlighting this typo. We have also reviewed the manuscript entirely to ensure consistency. 
Agreement among reviewers
In your paper you have mentioned a substantial agreement of (K = 0.2) but table 3 refers to this as a moderate agreement. Please correct. R: We are grateful for this precision, we have been amended and now reads "The evaluators demonstrated a moderate substantial agreement (K = 0.5556) for those guides classified as "recommendable with modifications" coinciding with a moderate quality of evaluation. However, the agreement was small (K = 0.2) when the quality of the documents was low and their use in clinical practice was not recommended." Discussion Please consider restructured your first sentence, paragraph 2. e.g. However, we identified low scores on other equally crucial domains for effective implementation including 'stakeholder involvement', methodological rigor and applicability'. R: Many thanks for the suggestion. The paragraph has been amended and now reads "However, we identified low scores on other equally crucial domains for effective implementation including such as 'stakeholder involvement', 'methodological rigour' and applicability"
Line 50 please change as important to is as important R: We have now amended, many thanks.
Your discussion addresses the adoption of guidelines into clinical practice and the processes to support this. However, this was not the question you were asking or supported by your results. Please restructure your discussion to address the results of your review. R: We appreciate the recommendation, thank you. The Discussion has been revised, and now it focuses on the comparation of the guides quality using the AGREE II tool and analysed relevant methodological factors related to the process of guideline development.
Conclusion
Your conclusion needs to summarize the findings of your review. R: This has been changed according the reviewer comments. The paragraph has been amended and now reads "Our findings indicate that quality of CPGs reviewed for the prevention of complications, management and care associated with VAD was moderate, being substantial the overall agreement among reviewers. There is a need to incorporate mechanisms of critical evaluation about the validity and reliability of selected guidelines within environments of practice, as a prior and essential requisite to knowledge mobilisation. The gaps identified with low CPG scores in critical domains for knowledge transfer may explain the suboptimal clinical impact of guidelines on healthcare practice. This is evidenced by the partly adherence of healthcare professionals to recommendations. We endorse propose the need to supplement clinical practice documents with implementation guides that ensure effective implementation."
Reviewer: 3 Reviewer Name: Nicole C Gavin Institution and Country: Royal Brisbane and Women's Hospital; Australia Please state any competing interests or state 'None declared': None declared.
Please leave your comments for the authors below Thank you for the opportunity to review this manuscript.
Title:
The title of the paper does not fit with the content of the manuscript. I was expecting the evidence in the CPG to be appraised but actually the quality of the guidelines themselves are being appraised. R: Thank you ever so much for your comments. The title has been changed to "Appraising the quality standards underpinning international clinical practice guidelines for the selection and care of vascular access devices: a systematic review of reviews".
Purpose:
The purpose of the study is different in the abstract and the introduction. R: This has been modified. 
Results:
The first paragraph needs further text detailing the contents of Figure 1 . R: We are grateful to the reviewer for this suggestion. The first paragraph has been modified to clarify the information and contents of the Figure. Overall assessment: This paragraph requires additional explanation and reference to Table 5 . Is it a percentage cutoff? if so this needs explaining. What modifications are required as eluded to in Table 5 ? This may require a paragraph in the methods section. R: The paragraph has been modified in order to clarify the information and the contents of the Table  2 . We have now amended to "The average score across the CPGs was moderate (median 62%), scores ranged from 38% to 90%. The best results following the global evaluation of the CPGs and their recommendations for practice of care were obtained by CPGs of the Ministry of Health in Spain, and NICE, being strongly recommended. In addition, three CPGs have been recommended, which would needed modifications on the domains of rigor and applicability; process of actualization; and two CPGs have not been recommended for use of clinical practice. (Table 2) (2004, 2016) . 'Mindlines' are collectively reinforced, internalised tacit guidelines, informed not only by brief reading and interactions with other peers, opinion leaders and patients. These 'ways of doing' are based on largely tacit knowledge that built on their early training and clinicians' own and colleagues' experience. We include the concept as it has been proposed (successfully, in our opinion…) as a balance to improvement approaches based on the sole use of guidelines. We suggest that even such use of documents relies on a social, behavioral and organizational process that requires consideration of experiences and the influence of opinion leaders etc… Paragraph 6, sentence 1 -needs rewording. R: Thank you, we have now amended to 'We endorse the need to supplement clinical practice guideline with implementation guides that facilitate and ensure effective implementation process to fidelity the best available evidence. We endorse the need to supplement clinical practice guideline with implementation guides that facilitate and ensure effective implementation process to fidelity the best available evidence, including result indicators associated with prevention and control of infections related to VAD.'
Limitations: Paragraph 1, sentence 4 -I think this sentence sums up what you have done and needs to be in the methods section too. R: We decided not to change this sentence "However, we performed a concordance analysis among the evaluators' findings for the recommendation of the guidelines." We considered it to be added information about this limitation. 
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